Toniolo R, Di Narda F, Bontempelli G, Ursini F
Department of Chemical Sciences and Technology, University of Udine, Italy.
Bioelectrochemistry. 2000 Jun;51(2):193-200. doi: 10.1016/s0302-4598(00)00073-8.
The redox properties of lacidipine (PyH2), one of the most pharmacologically active N-unsubstituted 1,4-dihydropyridines, have been studied by cyclic voltammetry and controlled potential electrolysis in acetonitrile, an aprotic solvent that is, at best, a mimic of the lipofilic layer of biological membranes. PyH2 undergoes a two-electron oxidation process involving two consecutive one-electron releases, the latter requiring potentials much less positive than the former. The overall process occurs through a primary one-electron step accompanied by a fast proton release, with the formation of a neutral radical (PyH*), which undergoes a further and quite easier one-electron step, thus providing the main ultimate product (PyH+) consisting in the protonated form of the parent pyridine derivative. This appears relevant for the anti-oxidant effect since the radical intermediate is much more prone to be oxidized than to be reduced, thus preventing the propagation of the oxidative chain reaction. The mentioned release of protons in the primary electrode step causes the overall process to be complicated by a parassite side reaction involving the coupling between one of the electrode products (H+) and the starting species. The protonation of PyH2 subtracts part of the original species from the electrode process because the parent cationic species (PyH3+) is no longer electroactive. This parassite reaction occurs rather slowly in the timescale of electroanalytical measurements (the relevant kinetic constant has been estimated to be 6.4 l mol(-1) s(-1)), thus markedly affecting the process only in the presence of relatively high PyH2 concentrations and progressively decreasing with the starting PyH2 concentration. All the products formed in the oxidation process (PyH+, H+ and PyH3+) have been identified by voltammetric evidences based on deep investigations on their cathodic behaviour. The advantageous anti-oxidant properties displayed by PyH2 with respect to those exhibited by phenolic anti-oxidants such as vitamin E are also discussed.
拉西地平(PyH2)是药理活性最强的N-未取代1,4-二氢吡啶之一,其氧化还原性质已通过循环伏安法和在乙腈(一种非质子溶剂,充其量只是生物膜脂溶性层的模拟物)中的控制电位电解进行了研究。PyH2经历一个双电子氧化过程,涉及两个连续的单电子释放,后者所需电位比前者正得多。整个过程通过一个主要的单电子步骤伴随着快速质子释放发生,形成一个中性自由基(PyH*),该自由基经历进一步且相当容易的单电子步骤,从而产生主要的最终产物(PyH+),即母体吡啶衍生物的质子化形式。这对于抗氧化作用似乎很重要,因为自由基中间体更倾向于被氧化而不是被还原,从而防止氧化链反应的传播。在初级电极步骤中提到的质子释放使整个过程因一个副反应而变得复杂,该副反应涉及电极产物之一(H+)与起始物质之间的耦合。PyH2的质子化使部分原始物质从电极过程中减少,因为母体阳离子物质(PyH3+)不再具有电活性。这个副反应在电分析测量的时间尺度上发生得相当缓慢(相关动力学常数估计为6.4 l mol(-1) s(-1)),因此仅在相对较高的PyH2浓度下才会显著影响该过程,并随着起始PyH2浓度的降低而逐渐减弱。氧化过程中形成的所有产物(PyH+、H+和PyH3+)已通过基于对其阴极行为深入研究的伏安证据得以鉴定。还讨论了PyH2相对于酚类抗氧化剂如维生素E所表现出的有利抗氧化性能。